Procter & Gamble Hygiene and Health Care financials

·FMCG & RetailChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹891cr−4.9% on Q1 FY26
Net profit
₹126cr−34.3% on Q1 FY26
EBITDA margin
19.1%−9.3 pts on Q1 FY26
EPS
₹38.90−34.3% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue891937−4.9%
EBITDA170266−36.1%
EBITDA margin19.1%28.4%−9.3 pts
Profit before tax170265−35.9%
Net profit126192−34.3%
EPS₹38.90₹59.17−34.3%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹891 crNet profit₹126 crNet margin14.2%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY27Jun 2026FY26Jun 2025FY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
22,474————
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
———574964
4,2458919374,2063,918
—−4.9%−77.7%+7.3%—
1,075170266970869
25.3%19.1%28.4%23.1%22.2%
1,037160257914810
791126192675678
18.6%14.2%20.5%16.1%17.3%
₹243.60₹38.90₹59.17₹207.95₹208.92
—−34.3%−71.5%−0.5%—
———471826
———−44.7−44.4
———426781
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHH₹6,923.50

Procter & Gamble Hygiene and Health Care Limited

· FMCG & Retail
₹ CrorePeersBAJAJCONJHSMcap ₹22,474 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Current/LTM
TTM · last close
Market Capitalization————22,473.7
- Cash, Equiv & ST Investments963.8573.7———
Revenue3,917.94,205.7937.0891.54,244.9
Growth %, YoY—+7.3-77.7-4.9—
EBITDA868.6970.2266.2170.11,074.9
Margin %22.1723.0728.4119.0825.32
EBIT810.3913.7257.1160.51,037.0
Net Income678.1675.0192.1126.3790.7
Margin %17.3116.0520.5014.1618.63
EPS, Adj (current shares)208.92207.9559.1738.90243.60
Growth %, YoY—-0.5-71.5-34.3—
Cash from Operations825.8470.5———
Capital Expenditures-44.4-44.7———
Free Cash Flow781.3425.9———
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Procter & Gamble Hygiene and Health Care financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Procter & Gamble Hygiene and Health Care (NSE: PGHH) had a market capitalisation of ₹22,238 crore at the 30 October 2026 close (₹6,851.00 a share), a PE ratio of 28.1 on the last four quarters' profit and a price-to-book ratio of 29.51. In the year to June 2026 its consolidated net profit was ₹126 crore on revenue of ₹891 crore. It had no borrowings on 31 March 2026. Promoters held 70.64% of the shares on 30 September 2026.

Share price used
₹6,851.00 · 30 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Procter & Gamble Hygiene and Health Care at a glance · consolidated

Market cap
₹22,238 Crat ₹6,851.00 · 30 Oct close
PE ratio (last 4 quarters)
28.1176.1 on the year to June 2026 profit
Price to book (PB)
29.51book value ₹232.12 a share
Debt to equity
0.00net cash ₹568 Cr
Promoter holding
70.64%unchanged vs 30 Jun 202630 September 2026
Dividend yield
3.72%₹255 a share in 12 months

Questions

What is the Procter & Gamble Hygiene and Health Care PE ratio today?

Procter & Gamble Hygiene and Health Care's PE ratio is 28.1 at the 30 October 2026 close (₹6,851.00 a share): a market capitalisation of ₹22,238 crore divided by consolidated net profit of ₹791 crore over the last four quarters (Q2 FY26 to Q1 FY27). On the year to June 2026 net profit (₹126 crore) it is 176.1.

What is the Procter & Gamble Hygiene and Health Care PB ratio (price to book value)?

Procter & Gamble Hygiene and Health Care's price-to-book (PB) ratio is 29.51 at the 30 October 2026 close: a market capitalisation of ₹22,238 crore divided by shareholders' equity (book value) of ₹753 crore on 31 March 2026. That is a book value of ₹232.12 per share against a share price of ₹6,851.00.

What is the Procter & Gamble Hygiene and Health Care net worth?

Procter & Gamble Hygiene and Health Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹753 crore on 31 March 2026, up 2.2% from ₹737 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹22,238 crore at the 30 October 2026 close.

What is the Procter & Gamble Hygiene and Health Care market cap?

Procter & Gamble Hygiene and Health Care's market capitalisation was ₹22,238 crore at the 30 October 2026 close: 3.25 crore shares at ₹6,851.00 each.

Is Procter & Gamble Hygiene and Health Care debt free?

Yes. Procter & Gamble Hygiene and Health Care had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹568 crore of cash, bank balances and current investments.

What is the Procter & Gamble Hygiene and Health Care debt to equity ratio?

Procter & Gamble Hygiene and Health Care's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹753 crore. A year earlier, on 31 March 2025, it was 0.00.

What is the Procter & Gamble Hygiene and Health Care book value per share?

Procter & Gamble Hygiene and Health Care's book value per share was ₹232.12 on 31 March 2026: shareholders' equity of ₹753 crore divided by the 3.25 crore shares in issue, up 2.2% from ₹227.05 a year earlier. The share price at the 30 October 2026 close was ₹6,851.00.

What is the Procter & Gamble Hygiene and Health Care EPS?

Procter & Gamble Hygiene and Health Care's basic earnings per share (EPS) were ₹38.90 in the year to June 2026, against ₹59.17 in the year to June 2025. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹243.59.

What are the Procter & Gamble Hygiene and Health Care latest quarterly results?

Procter & Gamble Hygiene and Health Care's latest results are for Q1 FY27 (April–June 2026), filed on 29 July 2026: consolidated net profit ₹126 crore, down 34.3% from ₹192 crore in Q1 FY26; revenue from operations ₹891 crore, down 4.9% year on year.

What is the Procter & Gamble Hygiene and Health Care dividend yield?

Procter & Gamble Hygiene and Health Care's dividend yield is 3.72% at the 30 October 2026 close: dividends of ₹255 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹6,851.00. They were ₹60 on 1 September 2026 and ₹195 on 5 February 2026 (interim + special).

What is the Procter & Gamble Hygiene and Health Care dividend in 2026 and its record date?

In 2026, Procter & Gamble Hygiene and Health Care has declared two dividends totalling ₹255 a share: ₹195 (interim + special) with record date 5 February 2026 and ₹60 with record date 1 September 2026.

What is the Procter & Gamble Hygiene and Health Care revenue and profit in the year to June 2026?

In the year to June 2026 (July 2025–June 2026), Procter & Gamble Hygiene and Health Care's consolidated net profit was ₹126 crore, down 34.3% from ₹192 crore in the year to June 2025, on revenue from operations of ₹891 crore (down 4.9%). Over three years, from the year to June 2023, net profit was down 81.4%.

What is the Procter & Gamble Hygiene and Health Care promoter holding?

Promoters held 70.64% of Procter & Gamble Hygiene and Health Care on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What is the Procter & Gamble Hygiene and Health Care shareholding pattern?

On 30 September 2026, Procter & Gamble Hygiene and Health Care's shares were held by promoters 70.64%, foreign portfolio investors (FII/FPI) 0.62%, domestic institutions (DII) 15.04% (including mutual funds at 7.41%) and retail and other non-institutional investors 13.70%. Over the year, FII holding was down 0.49 percentage points from 1.11% and DII holding was down 1.02 percentage points from 16.06%.

When are the Procter & Gamble Hygiene and Health Care next results?

Procter & Gamble Hygiene and Health Care will announce its Q2 FY27 results (July–September 2026) on Thursday, 12 November 2026, the date of the board meeting it has notified to the exchanges.

Where do these Procter & Gamble Hygiene and Health Care figures come from?

From Procter & Gamble Hygiene and Health Care's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.